Healthware Therapeutics included in the "Italy Life Sciences Report – 2021 Edition"

An interview with our CEO and Founder, Roberto Ascione, has been included in the GBR's publication dedicated to the Italian life sciences industry.

Roberto was asked to share the uptakes of the digital therapeutics industry and to specifically discuss Healthware's evolution in this scenario.

Our company has dramatically grown over the last five years through the acquisition of new companies that all share the same vision: to radically change the future of health for the better.

"My vision is not [only] delivering drugs, but empowering people to stay clear of diseases by caring about each person, individually and on their own terms. I call this approach a shift from cure to care as part of a seek-and-care healthcare model, much more focused on prevention and wellbeing", said Roberto.

The report also gathers insights from key executive voices across the value chain, from CEOs to cutting-edge innovators in the different areas of medicine. The contributors explored the impact of the pandemic on the Italian National healthcare system, focusing on the rise of digital health initiatives.

Read the full interview here